APA (7th ed.) Citation

S, S., K, A., S, K., S, O., A, N., M, K., . . . T, K. (2026). Anti-Integrin αvβ6 Autoantibodies Predict Response and Treatment Persistence to Advanced Therapies in Ulcerative Colitis. Clinical and translational gastroenterology, 17(3), e00990. https://doi.org/10.14309/ctg.0000000000000990

Chicago Style (17th ed.) Citation

S, Shibui, et al. "Anti-Integrin αvβ6 Autoantibodies Predict Response and Treatment Persistence to Advanced Therapies in Ulcerative Colitis." Clinical and Translational Gastroenterology 17, no. 3 (2026): e00990. https://doi.org/10.14309/ctg.0000000000000990.

MLA (9th ed.) Citation

S, Shibui, et al. "Anti-Integrin αvβ6 Autoantibodies Predict Response and Treatment Persistence to Advanced Therapies in Ulcerative Colitis." Clinical and Translational Gastroenterology, vol. 17, no. 3, 2026, p. e00990, https://doi.org/10.14309/ctg.0000000000000990.